PMCB Stock Catalyst: PharmaCyte Biotech Monetizes Stake in Femasys

Nov 24, 2025 · 3:34pm ET

Company strengthens cash position through strategic capital deployment.

Max move

+84.5%

High of day $1.20

Sparker timei

3:34pm ET

PMCB · Nov 24, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

PharmaCyte Biotech announced PharmaCyte Biotech successfully monetized its stake in Femasys, strengthening its cash position and demonstrating strategic capital deployment.

PharmaCyte Biotech, Inc. Common Stock has a free float of 6,072,500 shares and 6,795,800 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time PMCB sparks.

Download Sniper App →

Catch the next PMCB-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →